Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Venous Thromboembolism × Aspirin × Plasma cell × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 7 Myeloid 2 Sarcoma 1 Plasma cell 1 Gynecologic 1 CNS 1

Conditions

Multiple Myeloma 6 Neoplasms, Plasma Cell 4 Venous Thromboembolism 1 Recurrence 1

Interventions

apixaban 4 Rivaroxaban 2 enoxaparin sodium 1 Tinzaparin 1 Observation 1 Heparin, Low-Molecular-Weight 1 Enoxaparin 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 3 Not yet recruiting

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡